Disentangling the stringent response to engineer novel anti-persister drugs

Project description

Novel mechanistic insight into antibiotic resistance

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• natural sciences › biological sciences › microbiology › bacteriology
• engineering and technology › civil engineering › structural engineering
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2019-COG - ERC Consolidator Grant

Call for proposal

ERC-2019-COG
See other projects for this call

Funding Scheme

ERC-COG - Consolidator Grant

Host institution

UNIVERSITE LIBRE DE BRUXELLES

Address

Avenue Franklin Roosevelt 50
1050 Bruxelles
Belgium

Activity type

Higher or Secondary Education Establishments

Links

EU contribution

€ 2 000 000

Beneficiaries (1)

UNIVERSITE LIBRE DE BRUXELLES

Belgium

EU contribution

€ 2 000 000

Address

Avenue Franklin Roosevelt 50
1050 Bruxelles

Activity type

Higher or Secondary Education Establishments

Links